Radiation Oncology/Therapy: Page 175

CIVCO's EX3 Stepper gets FDA OK
By AuntMinnie.com staff writers
CIVCO Medical Solutions now can market its EX3 Stepper low-dose-rate and high-dose-rate ultrasound-guided brachytherapy system.
November 20, 2013
iCAD reports progress on 2 fronts
By AuntMinnie.com staff writers
Computer-aided detection (CAD) and radiation therapy firm iCAD is reporting growth in demand for its Xoft Axxent electronic brachytherapy system.
November 19, 2013
Elekta lands large S. Korean rad therapy order
By AuntMinnie.com staff writers
Radiation oncology firm Elekta said that Yonsei University Health System in South Korea has ordered four additional Elekta linear accelerators.
November 18, 2013
AccuBoost adds 3rd Ga. client
By AuntMinnie.com staff writers
Women's health firm AccuBoost announced that the Medical College of Georgia at Georgia Regents University has signed an agreement to install the AccuBoost image-guided partial-breast irradiation system.
November 17, 2013
DWI-MRI matches PET/CT in lymph node evaluation
By Wayne Forrest
Wednesday, December 4 | 3:10 p.m. - 3:20 p.m. | SSM17-02 | Room S505ABDiffusion-weighted MRI (DWI-MRI) is a viable, radiation-free alternative for evaluating lymph nodes, with findings that closely parallel those of FDG-PET/CT, researchers in India have concluded.
November 13, 2013
FDG-PET/CT tops MRI in colon cancer staging
By Wayne Forrest
Wednesday, December 4 | 3:00 p.m.-3:10 p.m. | SSM17-01 | Room S505ABWhile whole-body MRI is a feasible method for staging colon cancer patients, the modality does not quite reach the accuracy of FDG-PET/CT, according to a new study by Italian researchers.
November 13, 2013
PET/MRI complements PET/CT in NSCLC assessment
By Wayne Forrest
Wednesday, December 4 | 11:40 a.m.-11:50 a.m. | SSK17-08 | Room S505ABPET/MRI using a dedicated pulmonary MRI protocol and PET/CT show good agreement on thoracic tumor-node-metastasis staging for non-small cell lung cancer (NSCLC) patients, according to a study from Germany.
November 13, 2013
PET provides good lung images when combined with CT or MRI
By Wayne Forrest
Wednesday, December 4 | 11:00 a.m.-11:10 a.m. | SSK17-04 | Room S505ABDespite differences in attenuation correction techniques, the PET images from a PET/MRI system are equivalent to PET/CT in terms of quality and detection rate for FDG-positive lung lesions, according to researchers from Germany.
November 13, 2013
PET/MRI gets high marks for lymphoma staging
By Wayne Forrest
Wednesday, December 4 | 10:50 a.m.-11:00 a.m. | SSK17-03 | Room S505ABGerman researchers believe FDG-PET/MRI is a promising method for staging lymphoma, given that the hybrid modality's images are analogous to PET/CT without the ionizing radiation from CT.
November 13, 2013
FDG-PET/CT perhaps unnecessary for anal cancer staging
By Wayne Forrest
Monday, December 2 | 3:40 p.m.-3:50 p.m. | SSE08-05 | Room E353CIn this scientific session, Swedish researchers will discuss how contrast-enhanced CT appears to be sufficient for lymph node staging in squamous cell carcinoma of the anorectum and anal verge, decreasing the need for biopsy and PET/CT.
November 13, 2013
Tumor shrinkage post-treatment confers excellent prognosis in kidneys
By Eric Barnes
Thursday, December 5 | 10:40 a.m.-10:50 a.m. | SSQ10-02 | Room E450BShrinkage of 10% or more on CT post-treatment is highly predictive of good outcomes in renal cell carcinoma, according to a new study from Boston.
November 12, 2013
Controversy session probes CT radiation and risk
By Eric Barnes
Wednesday, December 4 | 4:30 p.m.-6:00 p.m. | SPSC42 | Room N228This session will take a new look at the data used to evaluate the association between radiation exposure and cancer risk. The participants will examine how those data have been used to quantify risk and assess the uncertainties inherent in those estimates.
November 12, 2013
Previous Page
Page 175 of 464
Next Page